VC  Broadview Ventures

http://www.broadviewventures.org





     Office Locations:

125 High Street, 9th Floor
Boston, MA 02110
Phone: 617-457-5944

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Broadview Ventures, Inc. is associated with the Paris based Foundation Leducq. In 2008, the trust of the Leducq Foundation created a new company, Broadview Ventures, to accelerate the translation of scientific discoveries into clinical benefit in cardiovascular and neurovascular disease through targeted investment in support of early stage technology. Although associated with the Leducq Foundation, with which it shares an overlap of mission and philosophy, BV is constituted as an independent, for-profit venture philanthropy corporation. Profits from this company must be used for further targeted investment through Broadview Ventures, or for Leducq Foundation grant funding. Broadview Ventures is designed to help overcome the problem of the so called 'translation gap,' where very early stage companies find that their research is too advanced for traditional academic funding, but not sufficiently developed to attract conventional venture capital investment. As of 2009, Broadview Ventures had invested in percutaneous valve replacement and micro-RNA technology.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Christopher de Souza PhD
    Christopher H. Colecchi Managing Director
    Frederick Jones MD
    Maria Berkman MD
    Nichole Schiffer

     

    Portfolio companies include:


      Aggamin Biologics
        web link


      Allosteros Therapeutics
        web link


      Apama Medical
        web link


      Capricor
        web link


      CardiaLen
        web link


      CardiAQ Valve Technologies
        web link


      Cellaegis Devices
        web link


      DecImmune Therapeutics
        web link


      InfoBionic
        web link


      miRagen
        web link


      NuPulse
        web link


      Provasculon
        web link


      Remedy Pharmaceuticals
        web link


      VentriNova
        web link


      VGS
        web link


     

    Recent News: